Chargement en cours...
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
Histone deacetylase inhibitors (HDACis) have now emerged as a powerful new class of small-molecule therapeutics acting through the regulation of the acetylation states of histone proteins (a form of epigenetic modulation) and other non-histone protein targets. Over 490 clinical trials have been init...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3341130/ https://ncbi.nlm.nih.gov/pubmed/22416777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc.12.3 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|